CClinicalTrials.gg
CompletedNCT05239936Updated Jun 28, 2022

Urdu Version of Arthritis Impact Measurement Scales 2 Short Form:Reliability and Validity Study

An observational study in Quality of Life, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-06-28.

Sponsored by Riphah International University · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
165
Ages
18 Years to 80 Years
Sex
All
01

Study summary

In this study ,Investigators will observe the Reliability and Validity of Arthritis Impact Measurement Scale 2 Short Form translated in Urdu language in Pakistani population to check quality of life in patients suffering from Osteoarthritis.

Read the detailed description

The main aim of this study is to translate and culturally adapt AIMS2 SF into Urdu language and to investigate the reliability and validity of AIMS2 SF in Osteoarthritis patients among Urdu speaking Pakistani population.

The study will be completed in 5 steps such as translation ,synthesis ,back translation ,expert committee review and pre testing. The study will be a cross sectional survey .The result of the study helps to know the validity and reliability of AIMS2 SF in Urdu Version to check the quality of life .The reliability of the scale will be checked through internal consistency and test retest method .Internal consistency will be analyzed through Cronbach's alpha value to estimate whether each item of a scale is appropriate for assessing the underlying concept of its scale with 165 patients will be used.

02

Conditions studied

  • Quality of Life

Keywords

  • AIMS2 SF
  • Urdu
  • OA
  • ACR
03

In context

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Osteoarthritis is the leading cause of pain and disability and the most common joint disorder in our general population .According to high prevalence due to increasing age it is also increasing in the upcoming years .It causes narrow joint space and degeneration of cartilage

Inclusion criteria

  1. Male and Female Patient age 18 years or older.
  2. Diagnosed with OA of the knee , hip and hand .
  3. Patients diagnosed according to ACR criteria. 4 - X-RAY scored according to Kellgren and Lawrence Classification.

Exclusion criteria

Exclusion Criteria:

1 - Radiograph not older than 6 months . 2- Age less than 18 are excluded from this study.

05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
165 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Arthritis Impact Measurement Scale 2-Short Form

    Arthritis Impact Measurement Scale 2-Short Form was designed to study Arthritis outcomes .It is a self administrated ,multidimensional health status assessment tool. Arthritis Impact Measurement Scale 2-Short Form has been extensively validated and shown to be reliable in cross sectional studies and clinical trails

    Time frame: 1st day

Secondary outcomes

  1. Western Ontario and McMaster Universities Arthritis Index

    Western Ontario and McMaster Universities Arthritis Index is used in evaluation of hip and knee Osteoarthritis. This is consisting of 24 items which are further divided into 3 subscales. 1-pain (5 items) 2- Stiffness (2 items) 3- Physical Function (17)items

    Time frame: 1st day

07

Study locations

1 site
  • Ripah International University
    Faisalabad, Punjab 38000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 28, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05239936
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Feb 15, 2022
Start date
Jun 15, 2021
Primary completion
Feb 15, 2022
Completion
Feb 16, 2022
Last update
Jun 28, 2022

Study contacts

Muhammad Kashif
study chair · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion